Healthcare

University of Maryland project targets evaluation of AI medical imaging

An FDA-funded University of Maryland project will build a platform to evaluate AI medical-imaging systems for pulmonary-embolism detection.

The University of Maryland reported funding for a project to create a platform evaluating AI-enabled medical imaging systems. The platform is intended to assess systems that detect pulmonary embolism, a potentially dangerous blood clot blocking a pulmonary artery.

The project involves computer scientist Heng Huang and collaborators at the University of Maryland’s Institute for Health Computing. It is supported by funding from the U.S. Food and Drug Administration.

Rather than introducing a new diagnostic model directly into clinical care, the project focuses on evaluating imaging systems. This addresses the need to understand how AI tools perform when applied to medical images and clinically important conditions.

The development matters because independent evaluation is central to safe deployment of medical AI. A dedicated assessment platform could help researchers and regulators compare systems, identify weaknesses, and improve evidence supporting the use of imaging AI for pulmonary embolism detection.

Original source: University of Maryland

Related RAQI solutions

In-depth analysis on RAQI Insight

Work with RAQI